NGL Fine-Chem Limited (BSE: 524774)
Health Care · Pharmaceuticals · IN
Rs2,925.65
+0.01% today · +89.8% 1Y
NGL Fine-Chem Limited (BSE: 524774) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $186.76M.
Over the last twelve months the share price has gained 89.8%, trading between 1.26K and 3.60K.
Tweenvest scores NGL Fine-Chem Limited across four factors: quality 72/100, value 54/100, growth 75/100, dividend 21/100. Its strongest factor is growth.
524774 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $186.76M
- Revenue (TTM)
- $56.68M
- P/E
- 31.55
- EPS
- 92.72
- Dividend yield
- 0.06%
- Beta (5Y)
- 0.87
- 52-week high
- Rs3,595.00
- 52-week low
- Rs1,261.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.18M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ha Tay Pharmaceutical JSCHNX: DHT | $193.22M | ₫50,200.00 | 0.00% |
| Beacon Pharmaceuticals PLCDSE: BEACONPHAR | $192.63M | Tk102.70 | +0.10% |
| Korea United Pharm Inc.KOSE: A033270 | $189.84M | ₩17,860.00 | +1.88% |
| BioVersys AGSWX: BIOV | $187.08M | CHF25.40 | -4.15% |
| MINAPHARM PharmaceuticalsCASE: MIPH | $186.58M | EGP829.40 | +2.08% |
| NervGen Pharma Corp.NasdaqCM: NGEN | $186.01M | $1.73 | -2.81% |
| Yoda Pharmaceuticals Inc.TPEX: 7829 | $185.57M | NT$59.70 | +1.02% |
| Dawnrays Pharmaceutical (Holdings) LimitedSEHK: 2348 | $184.28M | HK$0.96 | -0.52% |
Figures last refreshed Oct 11, 2026.